Gabelli Funds 13F: Cuts DuPont de Nemours (DD) Stake by $378K

Gabelli Funds trimmed its position in DuPont de Nemours, Inc. (NYSE: DD) by 2,790 shares, a decrease of 1.04%, in its latest 13F filing reflecting holdings as of May 14, 2026. This adjustment leaves Gabelli with a total of 264,271 shares valued at approximately $35.8 million based on the stock's price of $135.64 on the filing date.

In this latest move, Gabelli has reduced its stake but continues to hold a significant position in the company. The fund's previous holdings amounted to 267,061 shares. This change suggests a slight shift in the fund's strategy regarding DuPont, though it still maintains a substantial investment in the company.

While Gabelli has made this reduction, other institutional investors have been active as well. Recently, Great Lakes Advisors trimmed its DuPont stake by 14%, selling around 145,000 shares. In contrast, Voloridge Investment Management opened a new position in DuPont, acquiring over 1.25 million shares. These mixed actions among institutional investors reflect varied perspectives on DuPont's future.

DuPont's stock is currently trading at $135.64, which is just below its 50-day moving average of $136.44. The stock has been fluctuating, recently trading well above its 52-week low of $92.49. The recent activity in the stock price indicates a cautious market sentiment, especially after the company reported a revenue growth of 4% in its last earnings report.

On the analyst front, DuPont has received a mix of ratings. On October 15, 2026, RBC Capital maintained an 'Outperform' rating with a price target of $160, down from $176 previously. Barclays initiated coverage with an 'Overweight' rating and a target of $156 on October 13, 2026. Meanwhile, JP Morgan downgraded its rating to 'Neutral' with a target of $145 on October 9, 2026. The consensus recommendation for DuPont is currently 'buy', with a mean price target of $170 based on 16 analyst opinions.

DuPont de Nemours, Inc. provides a range of technology-based materials and solutions across various sectors, including healthcare and industrial applications. The company is headquartered in Wilmington, Delaware, and employs around 15,000 people. This recent trimming by Gabelli Funds reflects ongoing adjustments by institutional investors amid a fluctuating market environment.

Looking ahead, investors will be watching for DuPont's next earnings report scheduled for November 5, 2026. The latest 13F filings show past positions and may not reflect current strategies, but they signal how institutional investors are positioning themselves in the market.